MeRIT Session I - Research-in-Progress

Wednesday, May 18, 2016: 7:00 PM-9:00 PM
155
MeRIT Project: Evaluation of health disparities and risk factors among hypertensive patients
Dr. Amber Crowley, PharmD, MS-MTM, BCPS, BCACP1, Dr. Angela Nagel, PharmD, BPS2, Dr. Nabila Ahmed-Sarwar, PharmD, BPS, Dr. Thomas Carroll, MD, PhD4 and Rhonda Cooper-DeHoff, PharmD, MS, FAHA, FCCP5
1Department of Pharmacy, UR Medicine Strong Memorial Hospital, Rochester, NY
2Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY
3Department of General Medicine and Palliative Care, UR Medicine Strong Memorial Hospital, Rochester, NY
4Dept of Pharmacotherapy and Translational Research; Division of Cardiovascular Medicine; Center for Pharmacogenomics, University of Florida, Gainesville, FL
156
MeRIT Project: Instituting a Clinical Pharmacy Case Management Approach to Improve Medication-Related Outcomes in Cirrhosis Patients after Hospital Discharge
Rima Mohammad, pharmD1, Vicki Ellingrod, PharmD, Jessica Mellinger, MD1, Randolph Regal, PharmD1 and Anna Lok, MD1
1University of Michigan
157
MeRIT Project: Comparison of Norepinephrine and Vasopressin Versus Norepinephrine Alone for Achievement of Hemodynamic Stability in Patients with Septic Shock
Drayton Hammond, Pharm.D., MBA, BCPS, BCCCP1, Jacob Painter, Pharm.D., Ph.D., MBA2, Heather Flowers, BS3 and Dr. Nikhil Meena, MD3
1Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR
2Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, AR
3University of Arkansas for Medical Sciences
158
MeRIT Project: Sulfonylureas and the risk of sudden death and ventricular arrhythmia -- interim results
Dr. Charles E. Leonard, PharmD, MSCE1, Ms. Colleen M. Brensinger, MS1, Dr. Christina L. Aquilante, PharmD2, Dr. Rajat Deo, MD, MTR1, Dr. James H. Flory, MD, MSCE3, Dr. Denise M. Boudreau, PhD, RPh, MS4, Dr. Joshua J. Gagne, PharmD, ScD5, Dr. Warren B. Bilker, PhD1, Ms. Margaret J. Mangaali, BS (Candidate)1 and Dr. Sean Hennessy, PharmD, PhD1
1University of Pennsylvania
2University of Colorado
3Cornell University
4Group Health Research Institute
5Harvard University
159
MeRIT - Venous Thromboembolism Prophylaxis in Morbidly Obese Critically Ill Patients
Dr. Young Lee, Pharm.D.
Pharmacy practice, Texas Tech University Health Sciences Center School of Pharmacy, Abilene, TX
<< Previous Session | Next Session >>